SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending amid debates over its valuation following earnings, with community members pointing to its high P/E ratio while others defend its growth potential and strategic positioning in AI. Discussions also involve commentary from CEO Alex Karp and contrasting opinions on the stock's future, including Michael Burry's short position. Overall, the conversation reflects uncertainty about whether Palantir's current market price aligns with its long-term prospects.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending amid community discussion around a failed confirmatory trial for its PMO therapies, overshadowing otherwise positive earnings reports. Investors are weighing the implications of the trial results on future revenue, particularly in light of Elevidys sales and potential impacts on payer coverage.  Debate centers on whether the market reaction is an overcorrection and if long-term prospects remain strong due to potential buyouts or positive developments in the pipeline.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels is trending amid mixed sentiment following earnings, with community discussions focusing on revenue beats versus EPS miss and potential risks related to debt and dilution. While some traders are securing profits, others see the dip as a buying opportunity, especially with ongoing developments in nuclear energy and rare earth elements. The stock's movement is also influenced by broader geopolitical factors affecting the rare earth sector.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amid discussions around Q3 earnings, potential short squeeze, and a possible partnership with Novo Nordisk. Community talking points revolve around the company's growth potential, expansion into new markets like comprehensive testing and international, and revenue acceleration, with some expressing concerns around profitability and volatility. Speculation around partnerships and target prices is also contributing to the heightened interest.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors discuss its upcoming earnings report and the recent unveiling of a new e-bike. Community members are debating the company's long-term viability, R2 launch, build quality, service center experiences, potential partnerships, and overall strategy in a competitive EV market.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending due to discussions around a potential bottom and upcoming Q3 earnings, with analysts projecting continued revenue growth and potential profitability. Community members are weighing the impact of a recent court case development and expressing frustration with the stock's suppressed price despite positive company performance. A new pipeline program and potential M&A activity are also being discussed as possible catalysts.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending due to a significant drop following the FDA's changed stance on clinical trial data for its Huntington's disease therapy, with the community debating the reasons and potential fallout; some speculate about regulatory setbacks and compare it to other biotech firms, while others see a buying opportunity amidst the volatility. The stock's movement is heavily discussed in the context of broader biotech industry trends and potential for future acquisitions.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to anticipation surrounding the Phase 3 HOPE-3 trial data release for its DMD treatment, deramiocel, expected in mid-November. Community discussions focus on the potential for positive results, mirroring earlier trial success, and what this could mean for FDA approval and market value. The recent failure of a Sarepta DMD trial is adding extra attention as investors look for alternative therapies.

Tidal Trust II - Defiance Daily Target 2x Short PLTR ETF

Defiance Daily Target 2x Short PLTR ETF

PLTZ is trending as traders anticipate a potential downturn for PLTR, with community members actively discussing shorting opportunities after recent earnings and amidst valuation concerns. Some traders are using PLTZ to bet against PLTR, citing its high P/E ratio and potential for a significant pullback, while others debate the timing and strategy for shorting the stock.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

DASH is experiencing a surge, with community members pointing to its low supply and comparing its potential to ZEC's previous moves. Some traders are noting DASH's undervaluation and increased trading volume, while others speculate about potential integrations and its role in the privacy coin sector. The community also highlights its strong performance amidst a sea of red, attracting day traders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Comcast struggles to win back customers due to growing problem

Comcast, which provides cable TV, phone, and internet services to consumers under the name Xfinity, is struggling to shake an alarming consumer trend that is impacting business, and it is making...

Google's Pixel Watch 3 and Anker's two-headed USB-C cable are our favorite deals this week

Google's last-gen Pixel Watch 3 is on sale for $199.99 ($100 off) for a limited time. There are plenty of good smartwatches out there, and Google's last-gen Pixel Watch 3 is one of them. Right now...

Verizon CEO sounds alarm on why customers are leaving in droves

Verizon is struggling to shake a consumer trend that continues to grow legs, especially after the phone carrier issued several price hikes over the past year for its services. The increases have...

Lightning Round: Wait for Nextracker to cool off a bit, says Jim Cramer

'Mad Money' host Jim Cramer weighs in on stocks including: SoundHound AI, Nextracker, Rocket Lab, D-Wave Quantum, and AT&T...

Telecom ETFs in Focus This Earnings Season 

The telecom sector surges ahead of the S&P 500 as Verizon and AT&T post solid Q3 results, fueling optimism for 2025 growth.

Lumen Posts Narrower-Than-Expected Q3 Loss, Revenues Down Y/Y

LUMN's third-quarter loss narrows sharply as AI-driven fiber demand, NaaS growth and major cost savings power optimism for 2026.

<ul><li>AT&amp;T has taken the National Advertising Division to court, accusing the watchdog of trying to silence its truthful ads criticizing T-Mobile’s marketing record.</li><li>The lawsuit said NAD’s cease-and-desist order violates AT&amp;T’s right to share verified information from NAD’s own public findings.</li><li>NAD decisions between 2022 and 2025 concluded that several T-Mobile ads were misleading.&nbsp;</li></ul>AT&amp;T Inc. (T) has filed a lawsuit against the National Advertising Division (NAD), alleging that the organization is attempting to suppress truthful statements about competitor T-Mobile US Inc. (TMUS).&nbsp;The telecom giant’s legal move follows a cease-and-desist letter from NAD demanding the immediate withdrawal of an AT&amp;T advertising campaign and related press materials.<h2 class="st-heading-2">Background</h2>AT&amp;T’s recent advertising campaign, “Ain’t Our First Rodeo,” highlighted alleged instances of false or unsubstantiated claims by T-Mobile.The dispute centers on AT&amp;T’s claim that NAD has found T-Mobile’s marketing to be misleading on at least 16 occasions over the past four years.&nbsp;<a href="https://stocktwits.com/symbol/T">AT&amp;T stock</a> traded over 1% lower on Thursday afternoon. On Stocktwits, retail sentiment around the stock shifted to ‘bearish’ from ‘bullish’ territory the previous day amid ‘high’ message volume levels.&nbsp;<figure class="image"><img style="aspect-ratio:940/111;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_30_134410_png_7d317521d8.webp" alt="T’s Sentiment Meter and Message Volume as of 01:30 p.m. ET on Oct. 30, 2025 | Source: Stocktwits" width="940" height="111"><figcaption>T’s Sentiment Meter and Message Volume as of 01:30 p.m. ET on Oct. 30, 2025 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Legal Clash Over Truthful Speech</h2>AT&amp;T’s complaint contends that NAD’s actions represent a “credible threat of imminent litigation,” after several television networks paused its commercials at NAD’s request.&nbsp;The company insists its marketing only summarizes information NAD itself has disclosed publicly and that any attempt to restrict such speech violates First Amendment principles.&nbsp;The lawsuit asks a federal court to confirm that NAD lacks authority to enforce demands that amount to censorship.According to AT&amp;T’s filing, T-Mobile has faced repeated reprimands from NAD for claims about its 5G reliability, home internet speeds, and “Price Lock Guarantee” offers.&nbsp;NAD decisions between 2022 and 2025 concluded that multiple T-Mobile ads were “unsupported” or “misleading.” AT&amp;T cited that despite those findings, T-Mobile has delayed implementing corrections.AT&amp;T stock has gained over 8% in 2025 and over 12% in the last 12 months.&nbsp;Also See:<a href="https://stocktwits.com/news-articles/markets/equity/etsy-names-kruti-patel-goyal-as-next-ceo-stock-slides-on-lower-sales-outlook/cLGZYvuR3w8">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/palantir-accuses-former-executives-of-stealing-what-does-ai-have-to-do-with-it/cLGF6SyR3xn">Palantir Accuses Former Executives Of Stealing: What Does AI Have To Do With It?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 AT&T store, building exterior, Fifth Avenue, New York City, New York, USA. 

AT&T Sues Advertising Watchdog Over Claims Of Truthful Speech Suppression

AT&T has taken the National Advertising Division to court, accusing the watchdog of trying to silence its truthful ads criticizing T-Mobile’s marketing record.

Equity

National Advertising Division’s decisions between 2022 and 2025 concluded that several T-Mobile ads were misleading. 

AT&T Files Lawsuit Against NAD to Defend Its Right to Make Truthful Claims About Competitors

AT&T Files Lawsuit Against NAD to Defend Its Right to Make Truthful Claims About Competitors AT&T Files Lawsuit Against NAD to Defend Its Right to Make Truthful Claims About Competitors PR Newswire...

Apple CEO's iPhone 17 pitch has clear message for users

It's safe to say that Apple's (AAPL) 2025 turned out to be a statement year.Case in point is its stellar stock market run this year, with the company topping $4 trillion in market value, pushing it...

AT&T and Thales Collaborate to Revolutionize IoT Deployments With New eSIM Solution

With over 5.8 billion IoT cellular connections expected globally by 2030 (GSMA Intelligence) powering everything from smart meters to wearable health trackers the need for secure, scalable, and...

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

Will Robinhood Markets ($HOOD) beat quarterly earnings? 
 
*Powered by Polymarket

T
AT&T Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest T News

TAT&T Inc